Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Shares of Point Biopharma Global Are Soaring Tuesday

TheMotleyFool

0 0

Why Shares of Point Biopharma Global Are Soaring Tuesday: https://g.foolcdn.com/editorial/images/749685/physician-monitoring-patients-onscreen-vitals.jpg

Shares of Point Biopharma Global (NASDAQ: PNT) were up by more than 85% as of 11:45 a.m. ET on Tuesday after the healthcare company entered into a buyout agreement. The stock is up more than 70% this year.

Point Biopharma is a clinical-stage company that focuses on therapies that bind to cells to fight cancer. On Tuesday, Eli Lilly agreed to pay roughly $1.4 billion to buy the company. The deal, set at $12.50 a share, represents a premium of roughly 87% to Point's closing price on Monday and 68% to the 30-day volume-weighted average price.

Point's board was unanimous in recommending that the company's stockholders agree to the deal, which is expected to close by the end of this year.

Source Fool.com

Like: 0

PNT

Share